Diagnosing and treating Mycobacterium kansasii
- PMID: 35762953
- DOI: 10.1097/01.JAA.0000824932.43060.3f
Diagnosing and treating Mycobacterium kansasii
Abstract
This article describes an 18-year-old immunocompetent patient who developed Mycobacterium kansasii, manifested with shortness of breath and a cavitary lung lesion seen on radiograph. Initial sputum smears were negative; however, after 2 weeks, the cultures grew M. kansasii and the patient was started on an antimycobacterial regimen.
Copyright © 2022 American Academy of Physician Associates.
References
-
- Aksamit TR, Philley JV, Griffith DE. Nontuberculous mycobacterial (NTM) lung disease: the top ten essentials. Respir Med . 2014;108(3):417–425.
-
- Alnaser A, Parperis K. Mycobacterium kansasii infection and microscopic polyangiitis: an unexpected association. Cureus . 2018;10(6):e2831.
-
- Bakula Z, Safianowska A, Nowacka-Mazurek M, et al. Short communication: subtyping of Mycobacterium kansasii by PCR-restriction enzyme analysis of the HSP65 gene. Biomed Res Int . 2013;2013:1–4.
-
- Brugnera MF, Miyata M, Zocolo GJ, et al. A photoelectrocatalytic process that disinfects water contaminated with Mycobacterium kansasii and Mycobacterium avium . Water Res . 2013;47(17):6596–6605.
-
- Dos Santos Carneiro M, de Souza Nunes L, De David SMM, et al. Nontuberculous mycobacterial lung disease in a high tuberculosis incidence setting in Brazil. J Bras Pneumol . 2018;44(2):106–111.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical